Temasek’s SeaTown to invest up to S$115 million in Singapore healthcare firm AddVita
Investment brings alternative investor close to full deployment of its US$1 billion-plus private capital fund
Add BT as a preferred source
[SINGAPORE] SeaTown Holdings, an investment manager indirectly owned by Temasek, said on Wednesday (May 21) it is committing up to S$115 million in Singapore healthcare and life sciences firm AddVita.
Offering medical and laboratory technologies, AddVita sells pharmaceutical products as well, to hospitals, clinics, pharmacies and healthcare providers throughout Asia, particularly South-east Asia.
It also buys companies, focusing on small and medium-sized distributors in the healthcare and life sciences sectors, using the so-called buy-and-build strategy.
TRENDING NOW
DBS completes US$1 billion significant risk transfer deal, a first for Singapore bank
About 1 in 7 Singapore families has income of at least S$30k a month; share almost doubled in 5 years
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Not in education, employment or training: Why more Hong Kong youths are opting out of work
